نتائج البحث

Lipid nanoparticle–based COVID-19 vaccines: Ensuring pharmaceutical stability, safety, and efficacy.

• Authors : Driscoll, David F^1,2

• Source: American Journal of Health-System Pharmacy. Dec2023, Vol. 80 Issue 24, p1847-1849. 3p.

تفاصيل العنوان

The skin you're in: Design of experiments optimization of lipid nanoparticle self-amplifying RNA formulations in human skin explants

• Authors : Blakney, AK; McKay, PF; Ibarzo Yus, B ...

Subjects: Science & Technology; Physical Sciences; TechnologyUnited States

تفاصيل العنوان

Practical Guidance for the Use of Patisiran in the Management of Polyneuropathy in Hereditary Transthyretin-Mediated Amyloidosis.

• Authors : Dixon, Stacy (AUTHOR); Kang, Xuan (AUTHOR); Quan, Dianna (AUTHOR)

• Source: Therapeutics & Clinical Risk Management. Nov2023, Vol. 19, p973-981. 9p.

تفاصيل العنوان

Polymeric and Lipid Nanoparticles: Which Applications in Pediatrics?

• Authors : Nieto González, Noelia¹ (AUTHOR) ; Obinu, Antonella² (AUTHOR) ; Rassu, Giovanna² (AUTHOR)

• Source: Pharmaceutics. May2021, Vol. 13 Issue 5, p670. 1p.

تفاصيل العنوان

Notes from the Field: Safety Monitoring of Novavax COVID-19 Vaccine Among Persons Aged ≥12 Years - United States, July 13, 2022-March 13, 2023.

• Authors : Romanson B; Moro PL; Su JR

Subjects: COVID-19 Vaccines* ; COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control

• Source: MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2023 Aug 04; Vol. 72 (31), pp. 850-851. Date of Electronic Publication: 2023 Aug 04.Publisher: U.S. Centers for Disease Control Country of Publication: United States NLM ID: 7802429 Publication Model: Electronic

تفاصيل العنوان

Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines - United States, October 2022.

• Authors : Rosenblum HG; Wallace M; Godfrey M

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19 Vaccines*; Vaccination COVID-19 vaccine booster shotSARS-CoV-2 variants

• Source: MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2022 Nov 11; Vol. 71 (45), pp. 1436-1441. Date of Electronic Publication: 2022 Nov 11.Publisher: U.S. Centers for Disease Control Country of Publication: United States NLM ID: 7802429 Publication Model: Electronic

تفاصيل العنوان

Interim Recommendation of the Advisory Committee on Immunization Practices for Use of the Novavax COVID-19 Vaccine in Persons Aged ≥18 years - United States, July 2022.

• Authors : Twentyman E; Wallace M; Roper LE

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*SARS-CoV-2 variants

• Source: MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2022 Aug 05; Vol. 71 (31), pp. 988-992. Date of Electronic Publication: 2022 Aug 05.Publisher: U.S. Centers for Disease Control Country of Publication: United States NLM ID: 7802429 Publication Model: Electronic

تفاصيل العنوان

Alnylam Files Patent Infringement Suit Against Tekmira.

Subjects: THERAPEUTICS; ACTIONS & defenses (Law); PATENT infringementMASSACHUSETTS; UNITED StatesALNYLAM Pharmaceuticals Inc.; TEKMIRA Pharmaceuticals Corp.

• Source: Biomedical Market Newsletter; 1/21/2012, Vol. 21, p1-2, 2p

تفاصيل العنوان

The Advisory Committee on Immunization Practices' Recommendation for Use of Moderna COVID-19 Vaccine in Adults Aged ≥18 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA COVID-19 Vaccines - United States, February 2022.

• Authors : Wallace M; Moulia D; Blain AE

Subjects: Advisory Committees* ; Centers for Disease Control and Prevention, U.S.* ; Health Planning Guidelines*

• Source: MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2022 Mar 18; Vol. 71 (11), pp. 416-421. Date of Electronic Publication: 2022 Mar 18.Publisher: U.S. Centers for Disease Control Country of Publication: United States NLM ID: 7802429 Publication Model: Electronic

تفاصيل العنوان

The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5-11 Years - United States, November 2021.

• Authors : Woodworth KR; Moulia D; Collins JP

Subjects: Practice Guidelines as Topic*; COVID-19 Vaccines/COVID-19 Vaccines/COVID-19 Vaccines/*administration & dosage; Advisory Committees

• Source: MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2021 Nov 12; Vol. 70 (45), pp. 1579-1583. Date of Electronic Publication: 2021 Nov 12.Publisher: U.S. Centers for Disease Control Country of Publication: United States NLM ID: 7802429 Publication Model: Electronic

تفاصيل العنوان